Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.
about
Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune SuppressionFrequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapyLongitudinal changes of peripheral blood DC subsets and regulatory T cells in Chinese chronic HIV-1-infected patients during antiretroviral therapy.HIV-associated chronic immune activation.Regulatory T cells in HIV immunotherapyNormalization of FoxP3(+) regulatory T cells in response to effective antiretroviral therapy.The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation.CD4+FOXP3+ Regulatory T-Cell Subsets in Human Immunodeficiency Virus Infection.Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals.Epigenetic modification of FOXP3 in patients with chronic HIV infection.Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach.Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infection.Regulatory T cells in HIV infection: can immunotherapy regulate the regulator?Inequalities and duality in gene coexpression networks of HIV-1 infection revealed by the combination of the double-connectivity approach and the Gini's method.Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls.Regulatory T Cell Effect on CD8+ T Cell Responses to Human Herpesvirus 8 Infection and Development of Kaposi's Sarcoma.T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment.Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).Maraviroc reduces the regulatory T-cell frequency in antiretroviral-naive HIV-infected subjects.Potential Role of Vδ2+ γδ T Cells in Regulation of Immune Activation in Primary HIV Infection.HIV and Tuberculosis co-infection impacts T-cell activation markers but not the numbers subset of regulatory T-cells in HIV-1 infected patients.Regulatory T cells and chronic immune activation in human immunodeficiency virus 1 (HIV-1)-infected children.Treatment Intensification in HIV-Infected Patients Is Associated With Reduced Frequencies of Regulatory T Cells.
P2860
Q26744626-32789B96-03DF-4F5A-B6B1-F8CCC246EA29Q28741958-5B80DC6F-5F6E-4E2F-BB28-45A5FCE5D887Q34305055-B39061CB-B285-404E-8480-4067EA266AF1Q34653277-BABC580F-1E3C-4386-9342-F2934B1D93BAQ34725547-23BB037D-BEBA-4664-93E9-10EED7A81DCCQ34764366-C9504E78-0E4E-4A37-9B8D-ADB5D7DA8186Q34789326-E2FBB079-7554-4CA7-9C0D-E6DBF8D40BFCQ37054806-694AD85E-F5E2-4379-AC47-DDF8B6528D8EQ37204127-5742B569-A671-4686-9B28-678D541E0253Q37412137-6DE24892-A247-495F-9FDD-BFE359AA6EFAQ37629663-D93AD370-02D2-4E3E-861C-D754FFBFB387Q37706839-6C4491CA-D6D4-4D77-AFDA-4B52152C104BQ38068406-36FB4D7F-A422-4CDA-91DE-9D04E0AAE954Q38603395-B4835C2C-AFC9-4AB2-BC20-F9B739ACC5D8Q40094624-D98963D5-2DF0-4446-94E4-00891C01C987Q40358884-3FFBD615-0F3A-4B2A-BC89-B511B059150BQ40716958-83134DB0-9476-489F-A227-488EF55AAD22Q40909527-2C36DB67-E409-47C5-B661-A9682FFCE7A9Q42222937-FBD0B5E5-6F0F-46F0-AAAB-D5F958C596D2Q42367938-66802592-1C3B-4F76-B9C5-0630AF4502B0Q43646296-15B29060-CFEB-4660-B681-D64240E4B5E0Q44442856-62647703-BD72-4DE5-86FF-2D6BA1563831Q54211966-44F39F93-8009-497E-93B0-ED48DCFBECAA
P2860
Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Relationship between regulator ...... upting antiretroviral therapy.
@ast
Relationship between regulator ...... upting antiretroviral therapy.
@en
type
label
Relationship between regulator ...... upting antiretroviral therapy.
@ast
Relationship between regulator ...... upting antiretroviral therapy.
@en
prefLabel
Relationship between regulator ...... upting antiretroviral therapy.
@ast
Relationship between regulator ...... upting antiretroviral therapy.
@en
P2093
P2860
P50
P1433
P1476
Relationship between regulator ...... upting antiretroviral therapy.
@en
P2093
ANRS 116 SALTO study group
Christophe Piketty
Céline Didier
Jean-Paul Viard
Lambert Assoumou
Laurence Weiss
Marianne Burgard
Pierre-Marie Girard
Vladimira Donkova-Petrini
P2860
P304
P356
10.1371/JOURNAL.PONE.0011659
P407
P577
2010-07-21T00:00:00Z